Pharmacy Forward: What Evernorth's $100M AI Investment Is For
Evernorth, Cigna's health services subsidiary, launched Pharmacy Forward on July 1, 2026, backed by $100 million in AI investment through 2028. The program aims to use AI across the specialty pharmacy chain, targeting a 50% reduction in authorization times and clinical documentation time, plus a $400 million value return by end of 2028. It focuses on administrative and logistical tasks, not medical decisions.
On July 1, 2026, Evernorth, the health services subsidiary of Cigna, launched Pharmacy Forward, an AI initiative with a $100 million investment through 2028 to optimize the specialty pharmacy chain. The program starts with Accredo Specialty Pharmacy, which serves patients with chronic and complex conditions. The goals include halving the time from prescription receipt to drug delivery, cutting clinical documentation time by up to 50%, placing 90% of patients within one-day ground delivery reach, maintaining medication adherence above the 80% industry standard, and increasing use of personalized digital pathways by 25%. Evernorth expects $400 million in value by end of 2028, though these are projections, not measured results. The AI focuses on prior authorization, documentation completeness, eligibility checks, and logistics, under clinical team supervision, not on diagnosis or prescription. The initiative reflects a broader industry shift toward administrative AI in US healthcare, with executives Matt Perlberg and Katya Andresen leading the announcement. However, all gains remain targets without external validation or operational track record, so the program's real benefit to patients will be judged by 2028.
Source: ActuIA —
original